Lung cancer cells are able to take advantage of a person’s immune system, specifically T cells, to protect the tumor, according to new research recently published in Cancer Immunology Research.

Affinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung technology ...

A team of researchers at VCU Massey Comprehensive Cancer Center has identified a new pathway through which mutations in the tumor suppressor p53 gene—found very frequently in human tumors—hijack DNA ...

Daiichi Sankyo announced that the first patient has been dosed in the global phase 3 TROPION-Lung17 trial. The study is evaluating DATROWAY in patients with locally advanced or metastatic nonsquamous ...

Abenacianine, a fluorescent imaging agent, received FDA fast track status for enhancing tumor visualization during lung cancer surgery, showing safety and efficacy in phase 2 trials. Alecensa ...

NEW YORK, Dec. 2, 2025 /PRNewswire/ -- The Lung Cancer Research Foundation® (LCRF) awarded its annual 2025 Scientific Grant Program awards, funding another $1.65 million in new research. This year's ...

Lung cancer remains the world’s deadliest cancer, and cigarette smoke is its chief culprit. Chemicals in tobacco, such as polycyclic aromatic hydrocarbons (PAHs), damage DNA and trigger the mutations ...

People at high risk of lung cancer will soon be able to receive the first ever experimental vaccine designed to prevent the disease, in a world-first clinical trial led by researchers at UCL and the ...

Fred Hutch Cancer Center – Proton Therapy lung cancer specialist John Kang, MD, PhD, recently attended the American Society for Radiation Oncology (ASTRO) conference in Seattle. Scientific conferences ...

This year, more than 226,000 people will be diagnosed with lung cancer, and approximately 125,000 Americans will lose their lives to it; making it the leading cause of cancer-related deaths. I live ...

Foundation funds five new research projects, bringing 2025 total to $5.2 million NEW YORK, Jan. 6, 2026 /PRNewswire/ -- The Lung Cancer Research Foundation® (LCRF) recently awarded five new research ...